These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31170526)

  • 1. How can we improve the physical stability of co-amorphous system containing flutamide and bicalutamide? The case of ternary amorphous solid dispersions.
    Pacult J; Rams-Baron M; Chmiel K; Jurkiewicz K; Antosik A; Szafraniec J; Kurek M; Jachowicz R; Paluch M
    Eur J Pharm Sci; 2019 Aug; 136():104947. PubMed ID: 31170526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How can we improve the physical stability of co-amorphous system containing flutamide and bicalutamide? The case of ternary amorphous solid dispersions.
    Pacułt J; Rams-Baron M; Chmiel K; Jurkiewicz K; Antosik A; Szafraniec J; Kurek M; Jachowicz R; Paluch M
    Eur J Pharm Sci; 2021 Apr; 159():105697. PubMed ID: 33568330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
    Andrews GP; AbuDiak OA; Jones DS
    J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Polymer Chain Length on the Physical Stability of Amorphous Drug-Polymer Blends at Ambient Pressure.
    Pacułt J; Rams-Baron M; Chrząszcz B; Jachowicz R; Paluch M
    Mol Pharm; 2018 Jul; 15(7):2807-2815. PubMed ID: 29791165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Dynamics, Recrystallization Behavior, and Water Solubility of the Amorphous Anticancer Agent Bicalutamide and Its Polyvinylpyrrolidone Mixtures.
    Szczurek J; Rams-Baron M; Knapik-Kowalczuk J; Antosik A; Szafraniec J; Jamróz W; Dulski M; Jachowicz R; Paluch M
    Mol Pharm; 2017 Apr; 14(4):1071-1081. PubMed ID: 28231007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-crystallization for enhanced dissolution rate of bicalutamide: preparation and evaluation of rapidly disintegrating tablets.
    Essa EA; Elbasuony AR; Abdelaziz AE; El Maghraby GM
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1215-1223. PubMed ID: 30661420
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular Factors Governing the Liquid and Glassy States Recrystallization of Celecoxib in Binary Mixtures with Excipients of Different Molecular Weights.
    Grzybowska K; Chmiel K; Knapik-Kowalczuk J; Grzybowski A; Jurkiewicz K; Paluch M
    Mol Pharm; 2017 Apr; 14(4):1154-1168. PubMed ID: 28241116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.
    Trivino A; Gumireddy A; Meng F; Prasad D; Chauhan H
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1277-1291. PubMed ID: 31111732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
    Prasad D; Chauhan H; Atef E
    J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring the Dissolution Mechanisms of Amorphous Bicalutamide Solid Dispersions via Real-Time Raman Mapping.
    Tres F; Patient JD; Williams PM; Treacher K; Booth J; Hughes LP; Wren SA; Aylott JW; Burley JC
    Mol Pharm; 2015 May; 12(5):1512-22. PubMed ID: 25872658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Planetary ball milling and supercritical fluid technology as a way to enhance dissolution of bicalutamide.
    Szafraniec J; Antosik A; Knapik-Kowalczuk J; Kurek M; Syrek K; Chmiel K; Paluch M; Jachowicz R
    Int J Pharm; 2017 Nov; 533(2):470-479. PubMed ID: 28363855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced dissolution of solid dispersions containing bicalutamide subjected to mechanical stress.
    Szafraniec J; Antosik A; Knapik-Kowalczuk J; Chmiel K; Kurek M; Gawlak K; Paluch M; Jachowicz R
    Int J Pharm; 2018 May; 542(1-2):18-26. PubMed ID: 29481948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
    Patil AL; Pore YV; Kuchekar BS; Late SG
    Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Method To Identify Physically Stable Concentration of Amorphous Solid Dispersions (I): Case of Flutamide + Kollidon VA64.
    Chmiel K; Knapik-Kowalczuk J; Jurkiewicz K; Sawicki W; Jachowicz R; Paluch M
    Mol Pharm; 2017 Oct; 14(10):3370-3380. PubMed ID: 28787567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleation and crystal growth in supersaturated solutions of a model drug.
    Lindfors L; Forssén S; Westergren J; Olsson U
    J Colloid Interface Sci; 2008 Sep; 325(2):404-13. PubMed ID: 18561941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tabletting solid dispersions of bicalutamide prepared using ball-milling or supercritical carbon dioxide: the interrelationship between phase transition and
    Antosik-Rogóż A; Szafraniec-Szczęsny J; Gawlak K; Knapik-Kowalczuk J; Paluch M; Jachowicz R
    Pharm Dev Technol; 2020 Nov; 25(9):1109-1117. PubMed ID: 32686538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of bicalutamide-poloxamer F68 solid dispersion systems.
    Sancheti PP; Vyas VM; Shah M; Karekar P; Pore YV
    Pharmazie; 2008 Aug; 63(8):571-5. PubMed ID: 18771004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the performance of melt-extruded poly(ethylene oxide)-bicalutamide solid dispersions: characterisation of microstructural properties using thermal, spectroscopic and drug release methods.
    Abu-Diak OA; Jones DS; Andrews GP
    J Pharm Sci; 2012 Jan; 101(1):200-13. PubMed ID: 21905037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of bicalutamide solid dispersions and improvement of the dissolution.
    Ren F; Jing Q; Tang Y; Shen Y; Chen J; Gao F; Cui J
    Drug Dev Ind Pharm; 2006 Sep; 32(8):967-72. PubMed ID: 16954109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.